
临床进展1型糖尿病GAD-alum
GAD-alum能长期推迟HLA-DR3-DQ2阳性1型糖尿病儿童发病
By MedXY|2026年10月4日
GAD-alum免疫治疗可显著延缓HLA-DR3-DQ2单倍型阳性儿童进展至3期1型糖尿病,凸显精准医学在自身免疫调控中的作用。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.